ArticleJournal of hematology & oncology2020

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy.

Fahmin Basher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.